| Application no. and date | 09747492.8 (espacenet) (Federated) (European Patent Register), 20090513 | | Patent/reg. no. and date | DK/EP 2288727, 20130710 | | Publication date | 20110302 | | Priority no. and date | US 127816 P, 20080514 | | EP pub. no. and date |
EP 2288727 20110302 | | Effective date | | | Applicant/owner | Genomic Health, Inc., 301 Penobscot Drive
Redwood City, CA 94063, US,
Bristol-Myers Squibb Company, Route 206 & Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | BOZ GHDX-034EP | | Inventor | BAKER, Joffre, B., 1400 Avery Street
Montara
CA 94037, US,
WATSON, Drew, 1950 Noel Drive
Los Altos
CA 94024, US,
MADDALA, Tara, 301 Penobscot Drive
Redwood City
CA 94063, US,
SHAK, Steven, 648 Fairway Circle
Hillsborough
CA 94010, US,
MAURO, David, J., 301 Penobscot Drive
Redwood City
CA 94063, US,
FORD, Shirin, K., 301 Penobscot Drive
Redwood City
CA 94603, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | C12Q 1/68 (2006.01) | | Title | Prædiktorer for patientrespons på behandling med EGF-receptorinhibitorer | | Int. application no. | US2009043823 | | Int. publication no. | WO2009140409 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
